相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease
Elles Konijnenberg et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Degree of genetic liability for Alzheimer's disease associated with specific proteomic profiles in cerebrospinal fluid
Lianne M. Reus et al.
NEUROBIOLOGY OF AGING (2020)
ApoE and clusterin CSF levels influence associations between APOE genotype and changes in CSF tau, but not CSF Aβ42, levels in non-demented elderly
Rosalinde E. R. Slot et al.
NEUROBIOLOGY OF AGING (2019)
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study
Alberto Lleo et al.
ALZHEIMERS & DEMENTIA (2019)
Predicting clinical decline and conversion to Alzheimer's disease or dementia using novel Elecsys Aβ(1-42), pTau and tTau CSF immunoassays
Kaj Blennow et al.
SCIENTIFIC REPORTS (2019)
Amsterdam Dementia Cohort: Performing Research to Optimize Care
Wiesje M. van der Flier et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Tau Kinetics in Neurons and the Human Central Nervous System
Chihiro Sato et al.
NEURON (2018)
Unbiased estimates of cerebrospinal fluid β-amyloid 1-42 cutoffs in a large memory clinic population
Daniela Bertens et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease
Niklas Mattsson et al.
EMBO MOLECULAR MEDICINE (2017)
Tau and neurodegenerative disease: the story so far
Khalid Iqbal et al.
NATURE REVIEWS NEUROLOGY (2016)
Use of amyloid-PET to determine cutpoints for CSF markers A multicenter study
Marissa D. Zwan et al.
NEUROLOGY (2016)
The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging
Brian A. Gordon et al.
BRAIN (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly
Jasmeer P. Chhatwal et al.
NEUROLOGY (2016)
High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's disease
Malin Degerman Gunnarsson et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects
Jon B. Toledo et al.
BRAIN (2015)
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia A Meta-analysis
Willemijn J. Jansen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age
Courtney L. Sutphen et al.
JAMA NEUROLOGY (2015)
The cerebrospinal fluid Alzheimer profile: Easily said, but what does it mean?
Flora H. Duits et al.
ALZHEIMERS & DEMENTIA (2014)
Concordance Between Cerebrospinal Fluid Biomarkers and [C-11] PIB PET in a Memory Clinic Cohort
Marissa Zwan et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics
Kristin R. Wildsmith et al.
MOLECULAR NEURODEGENERATION (2014)
Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42 A Cross-Validation Study Against Amyloid Positron Emission Tomography
Sebastian Palmqvist et al.
JAMA NEUROLOGY (2014)
Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease study
Wesley Jongbloed et al.
ALZHEIMERS & DEMENTIA (2013)
Physiological release of endogenous tau is stimulated by neuronal activity
Amy M. Pooler et al.
EMBO REPORTS (2013)
Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010
Thomas G. Beach et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Injury markers predict time to dementia in subjects with MCI and amyloid pathology
Ineke A. van Rossum et al.
NEUROLOGY (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People
Geert De Meyer et al.
ARCHIVES OF NEUROLOGY (2010)
Amyloid-β(1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease
Cees Mulder et al.
CLINICAL CHEMISTRY (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Niklas Mattsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
CSF biomarkers predict rate of cognitive decline in Alzheimer disease
M. I. Kester et al.
NEUROLOGY (2009)
CSF markers for incipient Alzheimer's disease
K Blennow et al.
LANCET NEUROLOGY (2003)
分享论文
